Medication-induced osteoporosis

Meng Yi Weng, Nancy E Lane

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Osteoporosis, a condition of low bone mass and microarchitectural deterioration, results in fractures with minimal trauma. Secondary osteoporosis is defined as bone loss resulting from either specific clinical disorders or medications. Some medications that can induce osteoporosis are discussed. Specifically, this article reviews the pathogenesis of glucocorticoid-induced bone loss and demonstrates the means to successfully manage the condition with a combination of calcium and vitamin D supplementation and, depending on the severity of the bone loss, bisphosphonates or parathyroid hormone. In addition, the pathphysiology of bone loss from aromatase inhibitors in women, gonadotropin-releasing hormone agonists in men, anticonvulsant medications, and proton pump inhibitors is outlined. Finally, this review offers suggestions on evaluation and management of bone health in individuals treated with these medications for prolonged times.

Original languageEnglish (US)
Pages (from-to)139-145
Number of pages7
JournalCurrent Osteoporosis Reports
Volume5
Issue number4
StatePublished - Dec 2007

Fingerprint

Osteoporosis
Bone and Bones
Aromatase Inhibitors
Proton Pump Inhibitors
Diphosphonates
Parathyroid Hormone
Gonadotropin-Releasing Hormone
Vitamin D
Anticonvulsants
Glucocorticoids
Calcium
Health
Wounds and Injuries

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Medication-induced osteoporosis. / Weng, Meng Yi; Lane, Nancy E.

In: Current Osteoporosis Reports, Vol. 5, No. 4, 12.2007, p. 139-145.

Research output: Contribution to journalArticle

Weng, MY & Lane, NE 2007, 'Medication-induced osteoporosis', Current Osteoporosis Reports, vol. 5, no. 4, pp. 139-145.
Weng, Meng Yi ; Lane, Nancy E. / Medication-induced osteoporosis. In: Current Osteoporosis Reports. 2007 ; Vol. 5, No. 4. pp. 139-145.
@article{44032acb01e048ec8abf6361b38cc403,
title = "Medication-induced osteoporosis",
abstract = "Osteoporosis, a condition of low bone mass and microarchitectural deterioration, results in fractures with minimal trauma. Secondary osteoporosis is defined as bone loss resulting from either specific clinical disorders or medications. Some medications that can induce osteoporosis are discussed. Specifically, this article reviews the pathogenesis of glucocorticoid-induced bone loss and demonstrates the means to successfully manage the condition with a combination of calcium and vitamin D supplementation and, depending on the severity of the bone loss, bisphosphonates or parathyroid hormone. In addition, the pathphysiology of bone loss from aromatase inhibitors in women, gonadotropin-releasing hormone agonists in men, anticonvulsant medications, and proton pump inhibitors is outlined. Finally, this review offers suggestions on evaluation and management of bone health in individuals treated with these medications for prolonged times.",
author = "Weng, {Meng Yi} and Lane, {Nancy E}",
year = "2007",
month = "12",
language = "English (US)",
volume = "5",
pages = "139--145",
journal = "Foodborne Pathogens and Disease",
issn = "1744-165X",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Medication-induced osteoporosis

AU - Weng, Meng Yi

AU - Lane, Nancy E

PY - 2007/12

Y1 - 2007/12

N2 - Osteoporosis, a condition of low bone mass and microarchitectural deterioration, results in fractures with minimal trauma. Secondary osteoporosis is defined as bone loss resulting from either specific clinical disorders or medications. Some medications that can induce osteoporosis are discussed. Specifically, this article reviews the pathogenesis of glucocorticoid-induced bone loss and demonstrates the means to successfully manage the condition with a combination of calcium and vitamin D supplementation and, depending on the severity of the bone loss, bisphosphonates or parathyroid hormone. In addition, the pathphysiology of bone loss from aromatase inhibitors in women, gonadotropin-releasing hormone agonists in men, anticonvulsant medications, and proton pump inhibitors is outlined. Finally, this review offers suggestions on evaluation and management of bone health in individuals treated with these medications for prolonged times.

AB - Osteoporosis, a condition of low bone mass and microarchitectural deterioration, results in fractures with minimal trauma. Secondary osteoporosis is defined as bone loss resulting from either specific clinical disorders or medications. Some medications that can induce osteoporosis are discussed. Specifically, this article reviews the pathogenesis of glucocorticoid-induced bone loss and demonstrates the means to successfully manage the condition with a combination of calcium and vitamin D supplementation and, depending on the severity of the bone loss, bisphosphonates or parathyroid hormone. In addition, the pathphysiology of bone loss from aromatase inhibitors in women, gonadotropin-releasing hormone agonists in men, anticonvulsant medications, and proton pump inhibitors is outlined. Finally, this review offers suggestions on evaluation and management of bone health in individuals treated with these medications for prolonged times.

UR - http://www.scopus.com/inward/record.url?scp=38049055787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049055787&partnerID=8YFLogxK

M3 - Article

C2 - 18430387

AN - SCOPUS:38049055787

VL - 5

SP - 139

EP - 145

JO - Foodborne Pathogens and Disease

JF - Foodborne Pathogens and Disease

SN - 1744-165X

IS - 4

ER -